# ADCs Sector

Canonical URL: https://biopharmsignal.com/sector/adcs

ADCs, or antibody-drug conjugates, combine the targeting ability of antibodies with the payload of a cytotoxic drug. This sector page groups companies working on ADC platforms or lead ADC assets, especially in oncology where the modality has become increasingly important.

Companies currently grouped under ADCs: 6

## Recent Sector News

- 2026-05-14 16:05 EST — STRO — [Press Releases](https://biopharmsignal.com/news/STRO/press-releases-a937339a) — Source: Sutro Biopharma

## Companies

- [ADCT](https://biopharmsignal.com/company/ADCT) — ADC Therapeutics
- [AMAM](https://biopharmsignal.com/company/AMAM) — Ambrx Biopharma
- [IMGN](https://biopharmsignal.com/company/IMGN) — ImmunoGen
- [LEGN](https://biopharmsignal.com/company/LEGN) — Legend Biotech Corporation
- [STRO](https://biopharmsignal.com/company/STRO) — Sutro Biopharma
- [VINC](https://biopharmsignal.com/company/VINC) — Vincerx Pharma